Veracyte
Stock Forecast, Prediction & Price Target
Veracyte (VCYT) stock Price Target by analysts
$44
Potential upside: 45.59%
Veracyte price prediction
What is Veracyte stock analysts` prediction?
Veracyte stock forecast: Based on 1 Wall Street analysts` predicted price targets for Veracyte in the last 3 months, the avarage price target is $44, with a high forecast of $NaN. The average price target represents a 45.59% change from the last price of $30.22.
Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.
Veracyte stock Price Target by analysts
Full breakdown of analysts given Veracyte price targets
| Analyst name & company | Analyst win rate | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|---|
Mike Matson Needham | 0% 0/1 | 10 months ago | $44 45.59% upside | $35.85 | StreetInsider | Previous targets (0) |
Tejas Savant Morgan Stanley | 0% 0/1 | about 1 year ago | $26 -13.96% downside | $29.41 | TheFly | Previous targets (0) |
Unknown Morgan Stanley | N/A | over 3 years ago | $23 -23.89% downside | $21 | Benzinga | N/A |
Unknown Needham | N/A | over 3 years ago | $26 -13.96% downside | $21.46 | Benzinga | N/A |
Veracyte Financial Estimates
Veracyte Revenue Estimates
Veracyte EBITDA Estimates
Veracyte Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | ||
Revenue
% change YoY
| $219.51M N/A | $296.53M 35.08% | $361.05M 21.75% | Avg: $448.47M Low: $446.00M High: $450.81M avg. 24.21% | Avg: $492.93M Low: $488.91M High: $496.72M avg. 9.91% | ||
Net Income
% change YoY
| $-75.56M N/A | $-36.56M 51.61% | $-74.40M -103.51% | Avg: $9.75M Low: $-2.17M High: $31.23M avg. 113.11% | Avg: $20.89M Low: $11.62M High: $23.24M avg. 114.20% | ||
EBITDA
% change YoY
| $-62.31M N/A | $-15.15M 75.68% | $-49.40M -226.06% | Avg: $-52.51M Low: $-52.78M High: $-52.22M avg. -6.28% | Avg: $-57.72M Low: $-58.16M High: $-57.25M avg. -9.91% | ||
EPS
% change YoY
| -$1.11 N/A | -$0.51 54.05% | -$1.02 -100% | Avg: $0.11 Low: -$0.03 High: $0.43 avg. 111.11% | Avg: $0.26 Low: $0.16 High: $0.32 avg. 132.35% | ||
Operating Expenses
% change YoY
| $227.01M N/A | $236.03M 3.97% | $333.94M 41.48% | Avg: $300.80M Low: $299.14M High: $302.37M avg. -9.92% | Avg: $330.62M Low: $327.92M High: $333.16M avg. 9.91% | ||
FAQ
What is Veracyte stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 113.65% in 2025-2026.
We have gathered data from 5 analysts. Their low estimate is -2.17M, average is 9.75M and high is 31.23M.
What is Veracyte stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 17.06% in 2025-2026.
We have gathered data from 7 analysts. Their low revenue estimate is $446.00M, average is $448.47M and high is $450.81M.
What is Veracyte stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 121.73% in 2025-2026.
We have gathered data from 5 analysts. Their low earnings per share estimate is -$0.03, average is $0.11 and high is $0.43.
What is the best performing analyst?
In the last twelve months 1 analysts have been covering Veracyte stock. The most successful analyst is Mike Matson.